Your browser doesn't support javascript.
loading
Impact of sex on the efficacy and safety of panitumumab plus fluorouracil and folinic acid versus fluorouracil and folinic acid alone as maintenance therapy in RAS WT metastatic colorectal cancer (mCRC). Subgroup analysis of the PanaMa-study (AIO-KRK-0212).
Heinrich, K; Karthaus, M; Fruehauf, S; Graeven, U; Mueller, L; König, A O; von Weikersthal, L Fischer; Caca, K; Kretzschmar, A; Goekkurt, E; Haas, S; Alig, A H S; Kurreck, A; Stahler, A; Held, S; Sommerhäuser, G; Heinemann, V; Stintzing, S; Trarbach, T; Modest, D P.
Afiliação
  • Heinrich K; Department of Medicine III, University Hospital, LMU Munich, Munich; German Cancer Consortium (DKTK), Partner Site Munich, Munich. Electronic address: https://twitter.com/heinrich_kat.
  • Karthaus M; Department of Hematology and Oncology, Munich Hospital Neuperlach, Munich.
  • Fruehauf S; Dr Hancken Hospital, Stade.
  • Graeven U; Kliniken Maria Hilf GmbH, Moenchengladbach.
  • Mueller L; Oncology Practice UnterEms, Leer.
  • König AO; Department of Gastroenterology, University Medicine Göttingen, Goettingen.
  • von Weikersthal LF; Gesundheitszentrum St Marien, Amberg.
  • Caca K; Department of Gastroenterology, Hematology and Oncology, Hospital Ludwigsburg, Ludwigsburg.
  • Kretzschmar A; MVZ Mitte, Leipzig.
  • Goekkurt E; Practice of Hematology and Oncology (HOPE), Hamburg; University Cancer Center Hamburg (UCCH), Hamburg.
  • Haas S; Department of Hematology and Oncology, Friedrich-Ebert-Hospital, Neumünster.
  • Alig AHS; Department of Hematology, Oncology and Cancer Immunology, Charité-Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin.
  • Kurreck A; Department of Hematology, Oncology and Cancer Immunology, Charité-Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin.
  • Stahler A; Department of Hematology, Oncology and Cancer Immunology, Charité-Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin.
  • Held S; ClinAssess GmbH, Leverkusen.
  • Sommerhäuser G; Department of Hematology, Oncology and Cancer Immunology, Charité-Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin.
  • Heinemann V; Department of Medicine III, University Hospital, LMU Munich, Munich; German Cancer Consortium (DKTK), Partner Site Munich, Munich; Comprehensive Cancer Center, University Hospital (LMU), Munich.
  • Stintzing S; Department of Hematology, Oncology and Cancer Immunology, Charité-Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin; German Cancer Consortium (DKTK), German Cancer Research Centre (DKFZ), Heidelberg.
  • Trarbach T; Reha-Zentrum am Meer, Bad Zwischenahn; Department of Medical Oncology, West German Cancer Center, University Hospital Essen, Essen, Germany.
  • Modest DP; Department of Hematology, Oncology and Cancer Immunology, Charité-Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin; German Cancer Consortium (DKTK), German Cancer Research Centre (DKFZ), Heidelberg. Electronic address: domin
ESMO Open ; 8(4): 101568, 2023 08.
Article em En | MEDLINE | ID: mdl-37441876

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Neoplasias do Colo Tipo de estudo: Clinical_trials / Guideline Limite: Female / Humans / Male País como assunto: America central / Panama Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Neoplasias do Colo Tipo de estudo: Clinical_trials / Guideline Limite: Female / Humans / Male País como assunto: America central / Panama Idioma: En Ano de publicação: 2023 Tipo de documento: Article